All In Biotech

Drug Trial Radar · NCT05421923

The Pharmacokinetics (PK), Pharmacodynamics(PD), Safety, Tolerability of SR1375 in Healthy Volunteers

A Phase I Bridging Study to Evaluate the PK, PD, Safety and Tolerability of SR1375 in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Nov 29, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Jun 24, 2022

Primary completion

Oct 5, 2022

Study completion Oct 5, 2022

Sponsor

Sponsor type
Industry
First posted
Jun 16, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled phase I bridging study to evaluate the PK, PD, safety and tolerability of SR1375 in healthy subjects.

Conditions

  • Healthy

Interventions

  • SR1375 capsulesDrug

    Ascending single and multiple doses of SR1375 orally

  • PlaceboOther

    Ascending single and multiple doses of Placebo orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: On scheduled intervals from Day 1 up to Day 54
  2. TmaxTime frame: On scheduled intervals from Day 1 up to Day 54
  3. AUCTime frame: On scheduled intervals from Day 1 up to Day 54
  4. CL/FTime frame: On scheduled intervals from Day 1 up to Day 54
  5. t1/2Time frame: On scheduled intervals from Day 1 up to Day 54
  6. RacTime frame: On scheduled intervals from Day 1 up to Day 54

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Phase I clinical laboratory of Huashan Hospital

    Shanghai, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.